Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calavo Growers (CVGW) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Calavo Growers (CVGW) over the last 14 years, with Q4 2025 value amounting to $7.2 million.

  • Calavo Growers' Gains from Investment Securities rose 33680.39% to $7.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.9 million, marking a year-over-year increase of 3018.34%. This contributed to the annual value of $534000.0 for FY2025, which is 18.69% down from last year.
  • As of Q4 2025, Calavo Growers' Gains from Investment Securities stood at $7.2 million, which was up 33680.39% from $618000.0 recorded in Q3 2025.
  • Calavo Growers' 5-year Gains from Investment Securities high stood at $7.2 million for Q4 2025, and its period low was -$1000.0 during Q2 2025.
  • In the last 5 years, Calavo Growers' Gains from Investment Securities had a median value of $525000.0 in 2023 and averaged $1.0 million.
  • The largest annual percentage gain for Calavo Growers' Gains from Investment Securities in the last 5 years was 11541401.87% (2025), contrasted with its biggest fall of 10019.05% (2025).
  • Calavo Growers' Gains from Investment Securities (Quarter) stood at $1.8 million in 2021, then skyrocketed by 37.32% to $2.5 million in 2022, then crashed by 68.16% to $798000.0 in 2023, then soared by 107.02% to $1.7 million in 2024, then soared by 336.8% to $7.2 million in 2025.
  • Its Gains from Investment Securities was $7.2 million in Q4 2025, compared to $618000.0 in Q3 2025 and -$1000.0 in Q2 2025.